Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Revenue: 2023-2024

Historic Revenue for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $1.1 million.

  • CG Oncology's Revenue rose 3774.42% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 224.12%. This contributed to the annual value of $1.1 million for FY2024, which is 458.33% up from last year.
  • Per CG Oncology's latest filing, its Revenue stood at $1.1 million for FY2024, which was up 458.33% from $204,000 recorded in FY2023.
  • CG Oncology's Revenue's 5-year high stood at $1.1 million during FY2024, with a 5-year trough of $204,000 in FY2023.
  • Moreover, its 2-year median value for Revenue was $671,500 (2023), whereas its average is $671,500.
  • Data for CG Oncology's Revenue shows a peak YoY skyrocketed of 458.33% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows CG Oncology's Revenue stood at $204,000 in 2023, then soared by 458.33% to $1.1 million in 2024.